EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions

Rachel D Altshuler iD, Sandra A Mitchell iD, Diane C St Germain, Brennan Parmelee Streck iD, Alice P Chen, Lori M Minasian iD

Cancer · 15.10.2025 · 131 (S2)

DOI: 10.1002/cncr.35946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 22.10.2025. Verfasst von Rachel D Altshuler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As cancer treatments evolve, there is a growing need to assess, analyze, and integrate measurements of cancer treatment tolerability. This report describes the rationale, development, and outcomes of the National Cancer Institute Cancer Treatment Tolerability Consortium, and discusses future opportunities for cancer treatment tolerability research.

Schlagwörter

Stichwörter der Autor:innen

Common Terminology Criteria for Adverse Events (CTCAE)Patient‐Reported Outcomes version of the Common Terminology Criteria for Advers…cancer treatmentpatient‐reported outcomestolerabilitytoxicity

Autor:innen und Institutionen

  • Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Kelly Government Solutions, Rockville, Maryland, USA.
  • Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Rachel D Altshuler, Sandra A Mitchell, Brennan Parmelee Streck, Lori M Minasian

Zitieren

APA

Altshuler, R. D., Mitchell, S. A., St Germain, D. C., Streck, B. P., Chen, A. P., & Minasian, L. M. (2025). National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions. Cancer, 131(S2). https://doi.org/10.1002/cncr.35946

Vancouver

Altshuler RD, Mitchell SA, St Germain DC, Streck BP, Chen AP, Minasian LM. National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions. Cancer. 2025;131(S2). doi:10.1002/cncr.35946

BibTeX
@article{Altshuler2025,
  author = {Altshuler, Rachel D and Mitchell, Sandra A and St Germain, Diane C and Streck, Brennan Parmelee and Chen, Alice P and Minasian, Lori M},
  title = {National Cancer Institute Cancer Treatment Tolerability Consortium: Current status and future directions},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {S2},
  doi = {10.1002/cncr.35946}
}
Kostenlos starten →